semaglutide and brain health Dr. Heather Ferris: This is Your on Ozempic Semaglutide GLP-1 vs Ozempic vs

On your syringe, this means drawing to the 10-unit mark

Per the FDA label, if a patient has not lost at least 5% of baseline body weight after 12 weeks on the maintenance dose (2.4 mg), discontinuation should be considered

Whether you want medication-assisted options like semaglutide, a holistic plan, or a deeper understanding of your metabolism, Maui practitioners are known for compassionate, personalized support

These can include nausea, fatigue, or a settled feeling in the stomach

In phase III: Semaglutide 2.4 mg (STEP-1): nausea 44.2%, diarrhea 31.5%, vomiting 24.8% Tirzepatide 15 mg (SURMOUNT-1): nausea 29.2%, diarrhea 23.0%, constipation 16.8% Retatrutide 12 mg (TRIUMPH-1): nausea 37.2%, vomiting 22.0%, diarrhea 27.1% Key observation: tirzepatide shows the most favorable GI profile at equivalent dose, likely tied to the GIP component dampening GLP-1-mediated nausea signaling at the brainstem level